Welcome to Cambridge's website
- Cambridge is a successful and progressive healthcare company with an international focus.
- With offices in Ireland and the UK Cambridge specialise in the development, global registration, marketing, sales and distribution of innovative and classic specialist secondary care pharmaceutical products. Our products, which we have in-licensed or purchased outright from world-class partner companies, provide benefit in high profile therapeutic areas including the Central Nervous System (CNS) and Oncology.
- Cambridge's success has been as a result of its management team, which consists of dynamic individuals who have the skills, expertise and vision to build winning brands. Our board of directors includes some of the most respected and renowned professionals in the healthcare industry.
- Our vision is to become a leading provider of specialist pharmaceuticals for secondary care physicians. We will achieve this by developing market leading brands from targeted acquisitions and internal product development.

Business Development
Alliance is committed to continued growth via acquisition, in-licensing new opportunities and forming mutually beneficial business partnerships. Our management experience across a wide range of pharmaceutical brands and markets allows rapid assessment of opportunities. At this stage in Alliance’s development we are willing to look at all therapeutic areas. Whilst we are focussed on prescription pharmaceuticals, we are also exploring opportunities in semi-ethicals and related medical devices.
Innovation in Specialist Pharmaceuticals
- Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialisation expertise. Our focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS).
- We have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This, combined with our strong product portfolio and our ability to forge lasting relationships with global partners, has helped us generate substantial sales growth over the past 10 years.
- We are proud of our independence and entrepreneurial culture. Equally, our strong balance sheet and freedom from debt give us a solid foundation from which we continue to enhance our growth.
- Our focus is very firmly on the future and the opportunity to augment further targeted product acquisitions with our own internal development pipeline, bringing to market products that will help us fulfil previously unmet patient needs.